A head-to-head trial showed that its cervical cancer vaccine Cervarix produced two to six times as many antibodies as Merck & Co.'s Gardasil.
[The trial was sponsored by GlaxoSmithKline]
GOAL: Promote GSK Product, Cervarix
----
A new Mr Men book has been released to help promote anti-allergy medications.
'Mr Sneeze and His Allergies' was written by Adam Hargreaves, the son of Mr Men creator Roger Hargreaves, and published by Egmont Books.
[The book was sponsored by GlaxoSmithKline]
GOAL: Promote GSK products, Piriteze and Piriton.
----
Della Reese Touched By Diabetes
On the long-running CBS hit Touched by an Angel, Della Reese was a party to many miracles. Now in real life the actress hopes to create life-changing results for those suffering from diabetes.
She is now compensated as the national spokesperson for an educational awareness campaign called "Della Reese: Stronger Than Diabetes."
[The campaign was sponsored by GlaxoSmithKline]
GOAL: Promote GSK Product, Avandia
**Reese's doctor prescribed Avandia which targets insulin resistance by making the body more sensitive to the insulin it is already making.
"The medication is helping me a lot," Reese says. "I don't have to take insulin because I have been able to make these changes and take this medication."
In 2007 a prominent US clinician concluded that Avandia, a diabetes drug produced by UK pharmaceutical company GlaxoSmithKline (GSK) increases the risks of heart attack and death.
----
Fat: What No One is Telling You
PBS program on obesity, premiered April 11, 2007 on PBS
[The TV Programme was sponsored by GlaxoSmithKline]
GOAL: Promote GSK Product, Alli
----
Medical Conference on Childhood Depression
GlaxoSmithKline attempted to show that Paxil/Seroxat worked for depressed children
GOAL: Promote GSK Product, Seroxat
----
GlaxoSmithKline's Motto.
Committed to improving the quality of human life by enabling people to do more, feel better and live longer.
----
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
No comments: